Renal clearance and protein binding of melphalan in patients with cancerREECE, P. A; HILL, H. S; GREEN, R. M et al.Cancer chemotherapy and pharmacology. 1988, Vol 22, Num 4, pp 348-352, issn 0344-5704Article

Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humansREECE, P. A; SEDMAN, A. J; ROSE, S et al.Journal of clinical pharmacology. 1994, Vol 34, Num 11, pp 1126-1132, issn 0091-2700Article

Alteration in doxorubicin and doxorubicinol plasma concentrations with repeated courses to patientsMORRIS, R. G; REECE, P. A; DALE, B. M et al.Therapeutic drug monitoring. 1989, Vol 11, Num 4, pp 380-383, issn 0163-4356Article

Mexiletine removal by peritoneal dialysisJONES, T. E; REECE, P. A; FISHER, G. C et al.European journal of clinical pharmacology. 1983, Vol 25, Num 6, pp 839-840, issn 0031-6970Article

The effect of food on oral melphalan absorptionREECE, P. A; KOTASEK, D; MORRIS, R. G et al.Cancer chemotherapy and pharmacology. 1986, Vol 16, Num 2, pp 194-197, issn 0344-5704Article

Prednisolone protein binding in renal transplant patientsREECE, P. A; DISNEY, A. P; STAFFORD, I et al.British journal of clinical pharmacology. 1985, Vol 20, Num 2, pp 159-162, issn 0306-5251Article

Endralazine ― a new hydralazine-like antihypertensive with high systemic bioavailabilityREECE, P. A; COZAMANIS, I; ZACEST, R et al.European journal of clinical pharmacology. 1983, Vol 25, Num 4, pp 553-556, issn 0031-6970Article

Improved gas-liquid chromatographic method for measuring fenfluramine and norfenfluramine in heparinised plasmaMORRIS, R. G; REECE, P. A.Journal of chromatography. 1983, Vol 278, Num 2, pp 434-438, issn 0021-9673Article

Gabapentin does not affect antipyrine clearanceALLEN, E; TSANACLIS, L. M; WROE, S. J et al.Journal of clinical pharmacology. 1999, Vol 39, Num 9, pp 934-935, issn 0091-2700Article

Inhibition of tacrine oral clearance by cimetidineFORGUE, S. T; REECE, P. A; SEDMAN, A. J et al.Clinical pharmacology and therapeutics. 1996, Vol 59, Num 4, pp 444-449, issn 0009-9236Article

Lack of effect of tacrine administration on the anticoagulant activity of warfarinREECE, P. A; GARNETT, W. R; ROCK, W. L et al.Journal of clinical pharmacology. 1995, Vol 35, Num 5, pp 526-528, issn 0091-2700Article

A phas I study of doxifluridine as a five-day stepped-dose continous influsionOLVER, I. N; REECE, P. A; BISHOP, J. F et al.American journal of clinical oncology. 1990, Vol 13, Num 4, pp 308-311, issn 0277-3732, 4 p.Article

Disposition of unchanged cisplatin in patients with ovarian cancerREECE, P. A; STAFFORD, I; DAVY, M et al.Clinical pharmacology and therapeutics. 1987, Vol 42, Num 3, pp 320-325, issn 0009-9236Article

Effect of L-leucine on oral melphalan kinetics in patientsREECE, P. A; DALE, B. M; MORRIS, R. G et al.Cancer chemotherapy and pharmacology. 1987, Vol 20, Num 3, pp 256-258, issn 0344-5704Article

Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancerREECE, P. A; MORRIS, R. G; BISHOP, J. F et al.Cancer research (Baltimore). 1987, Vol 47, Num 11, pp 2996-2999, issn 0008-5472Article

In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: Novel capsid-binding inhibitors with potent antipicornavirus activityBARNARD, D. L; HUBBARD, V. D; SMEE, D. F et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1766-1772, issn 0066-4804, 7 p.Article